Plunkett Research Online: CSPC Pharmaceutical Group Limited

CSPC PHARMACEUTICAL GROUP LIMITED (CSPCY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

China Specialty Pharmaceutical Group Limited (CSPC), formerly China Pharmaceutical Group Limited, manufactures branded and generic drugs in China. It divides its operations into four lines of business: innovative drugs, generic drug, bulk drug and research & development. The innovative drug busine.....

CSPC Pharmaceutical Group Limited
Ticker: CSPCY
Exchange: PINX
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 852 28023011
Fax: 852 28024552
Address: No. 226 Huanghe Street
Hebei Province
Shijiazhuang, 050035 China

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Pharmaceutical Manufacturing
Contacts Description
Dongchen Cai Chairman of the Board/Co-CEO/Director
Chun Kwok Au Director
See More

Auditor: Deloitte Touche Tohmatsu
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: